價格 | 詢價 | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2024-12-27 |
中文名稱:抗 SARS-CoV-2 S Protein 納米抗體 (SAA1084)(RVV00169) | 英文名稱:Anti-SARS-CoV-2 S Protein Nanobody (SAA1084) |
純度規(guī)格: PAGE:>95% | 產(chǎn)品類別: 一抗 InVivo活性抗體 |
抗體名: Anti-SARS-CoV-2 S Protein Nanobody (SAA1084) | 靶點: S Protein |
宿主: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) | 適應(yīng)物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) |
克隆性: Monoclonal | 藥物對照抗體: Anti-SARS-CoV-2 S Protein Nanobody (SAA1084) |
Catalog No.
RVV00169
Species reactivity
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
VHH-8His-Cys-tag
Applications
ELISA
Target
S Protein
Purification
Purified by Nickel column.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P0DTC2
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2, Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Note
For research use only.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 一千萬元人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP2年
|
北京百普賽斯生物科技股份有限公司
|
2024-12-16 | |
¥3000 |
湖北艾普蒂生物工程有限公司
|
2023-08-09 | ||
¥580 |
康體生命
|
2024-12-26 |